Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, December 18, 2014
Technology Networks
 
Register | Sign in
Home Page>Application Notes

  Application Notes

Enantiomer Analysis using the Peregrine High Performance Capillary Ele

deltaDOT
Examples of Africa Chemistry

Syrris Ltd
Examples of FRX Applications for Demonstration

Syrris Ltd
Flow Aqueous Work-up Using FLLEX

Syrris Ltd
Heating on an Atlas Hotplate

Syrris Ltd
Improved cell viability assay performance using PrestoBlue® Reagent

Tecan Trading AG
Increasing Chemist Productivity in an Open-Access Environment

ACD/Labs
Indirect UV Analysis of Amino Acids using by Capillary Zone Electropho

deltaDOT
Microplate-Based Endotoxin Testing in GLP/GMP Environments with the Ve

Molecular Devices
<< 1 2 3 4 >>
showing results 10 to 18 of 36
Scientific News
Novel Agent Decreases Neuropathic Pain in Patients with Type 2 Diabetes
Promising profile of disease modification and pain reduction leads to proof of concept trials.
Barrier-Breaking Drug May Lead to Spinal Cord Injury Treatments
NIH-funded scientists take first step towards developing promising new drug.
Two Drugs are No More Effective Than One to Treat Common Kidney Disease
NIH study finds limited kidney benefit from more rigorous blood pressure treatment.
Antibiotic Resistance Threatens Future of Modern Medicine
Overuse and misuse of antibiotics, one of the key contributors to antimicrobial resistance (AMR).
Computer Model Sets New Precedent in Drug Discovery
New computational model can precisely simulate, predict therapeutic protein behaviors to help zero in on ideal drug design candidates.
New Drug for Common Liver Disease Improves Liver Health
An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the NIH.
'Rewriting' the Way to Make Natural Drug Compounds
Using an organism's own pathway to synthesize potential therapeutics.
MS Drug Candidate Shows Promise for Ulcerative Colitis
Positive new clinical data were released today on a drug candidate for ulcerative colitis that was first discovered and synthesized at The Scripps Research Institute.
New Technique has Profound Implications for Drug Development
The method, developed by Scripps Research Institute chemists, expands options for making pure batches of ‘one-handed’ molecules.
Team Discovers How Microbes Build a Powerful Antibiotic
Researchers discovery opens up new avenues of research into thousands of similar molecules.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn